Post-treatment Breast Imaging

Post-Tx Baseline & Goals - New Normal Nav

• Primary Goal: Detect recurrence/new primaries; differentiate from expected post-treatment changes.
• "New Normal" Establishment:
  • Treatment alters breast architecture (scars, seromas, fat necrosis).
  • Baseline imaging captures these changes for future comparison.
• Baseline Mammography Timing (Post-BCT):
  • Typically 6-12 months after completing Radiation Therapy (RT).

    ⭐ First post-RT mammogram: 6-12 months after RT completion is crucial for establishing a new baseline.

  • Earlier if clinically indicated.
• Surveillance:
  • Annual mammography.
  • Ultrasound/MRI for specific indications (e.g., dense breasts, high-risk).
• Challenge: Differentiating benign post-tx changes from recurrence.

Surgical Sequelae - Surgical Souvenirs

• Common Post-Op Changes (All Modalities):
  • Early: Seroma (clear fluid), hematoma (blood), edema, skin thickening. Usually resolve.
  • Late: Scar/fibrosis (spiculated, stable/shrinking), fat necrosis (oil cysts: lucent mammo, anechoic US; dystrophic calcifications: coarse, rim), architectural distortion.
  • Surgical clips: Mark lumpectomy bed.
• Lumpectomy Cavity: Evolves from fluid → granulation tissue → scar. Stability is key.
• Mastectomy: Absence of breast tissue; monitor chest wall.
• Reconstruction:
  • Implants: Check for rupture (e.g., linguine sign MRI for intracapsular).
  • Flaps (TRAM/DIEP): Monitor for fat necrosis, seroma.

⭐ > A post-surgical scar can mimic malignancy (spiculation) but stability or regression on serial imaging is reassuring; growth is a red flag.

Radiation & Systemic Rx - Ray & Rx Remnants

• Radiation Therapy (RT) Changes:
  • Acute (0-6 months): Skin thickening, ↑ breast density, edema, ill-defined haziness.
  • Developing (6-12 months): Peak skin changes, early fibrosis, architectural distortion may begin.
  • Chronic (>12 months): Established fibrosis, scarring, architectural distortion, fat necrosis (oil cysts, dystrophic calcifications), skin retraction, telangiectasias, volume ↓.
  • Calcifications: Typically benign, coarse, dystrophic; may appear 1-2 years post-RT.
  • ⭐ > Radiation-induced angiosarcoma is a rare but serious late complication, typically presenting 5-10 years post-RT.
• Systemic Therapy Changes:
  • Chemotherapy: Generally minimal direct breast imaging changes. May show tumor shrinkage if neoadjuvant. Ovarian suppression can induce menopausal changes (↓ density).
  • Hormonal Therapy:
    • Tamoxifen: Variable effects; can ↑ breast density in some postmenopausal women. Associated with endometrial changes.
    • Aromatase Inhibitors (AIs): Tend to ↓ breast density and promote glandular atrophy.

Recurrence Radar - Red Flag Recon

Key: Differentiate recurrence from benign changes.

• General Red Flags:

  • New/growing mass/density.
  • New/increasing suspicious microcalcifications.
  • Architectural distortion developing >2 years post-op.

• Modality Specific Signs:

  • Mammography:
    • New/enlarging opacity at/near surgical site.
    • New pleomorphic/linear microcalcifications.
  • Ultrasound (US):
    • New solid hypoechoic mass (irregular/spiculated).
    • Increased vascularity on Doppler.
  • MRI:
    • New enhancing mass (Type II/III kinetics).
    • New non-mass enhancement (NME) (segmental/ductal).

• Differentiating Benign Changes:

  • Scar: Stable/retracts over time. Initial distortion possible.
  • Fat Necrosis: Oil cysts, dystrophic Ca++ (rim/coarse). Predictable evolution.
  • Seroma: Simple fluid, resolves/shrinks.

⭐ Architectural distortion at the lumpectomy site developing >2 years post-treatment is highly suspicious for recurrence.

High‑Yield Points - ⚡ Biggest Takeaways

• Baseline mammogram post-treatment (lumpectomy/radiation) is crucial at 6-12 months.
• Differentiating scar (stable/shrinks) from recurrence (grows, new calcifications) is key.
• Fat necrosis is common; look for stability or pathognomonic lucent-centered calcifications.
• MRI has the highest sensitivity for detecting local recurrence, especially in dense breasts.
• Post-mastectomy imaging is typically for palpable concerns or high-risk individuals.
• New or enlarging axillary lymph nodes may indicate axillary recurrence.